Exponent (NASDAQ:EXPO) Price Target Raised to $90.00 at JPMorgan Chase & Co.

Exponent (NASDAQ:EXPO) had its price objective increased by JPMorgan Chase & Co. from $80.00 to $90.00 in a report issued on Friday,Benzinga reports. The firm currently has an overweight rating on the business services provider’s stock.

A number of other equities research analysts have also commented on the company. UBS Group set a $72.00 target price on Exponent and gave the company a “neutral” rating in a research report on Friday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a research note on Friday, July 17th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $81.00.

Exponent Trading Up 3.5%

NASDAQ:EXPO opened at $66.85 on Friday. The company has a market capitalization of $3.24 billion, a P/E ratio of 29.98 and a beta of 0.72. Exponent has a 12 month low of $51.91 and a 12 month high of $81.95. The firm has a fifty day simple moving average of $60.00 and a 200-day simple moving average of $65.23.

Exponent (NASDAQ:EXPO) last released its earnings results on Thursday, July 30th. The business services provider reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.55 by $0.05. The firm had revenue of $171.61 million for the quarter, compared to the consensus estimate of $144.99 million. Exponent had a return on equity of 29.63% and a net margin of 17.67%.The firm’s revenue was up 12.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.52 EPS. Equities analysts forecast that Exponent will post 2.28 EPS for the current year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Friday, September 4th will be paid a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, September 4th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.9%. Exponent’s dividend payout ratio (DPR) is presently 55.61%.

Insider Activity

In other Exponent news, CEO Catherine Corrigan sold 4,119 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $57.13, for a total value of $235,318.47. Following the completion of the transaction, the chief executive officer owned 106,670 shares in the company, valued at approximately $6,094,057.10. This represents a 3.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Joseph Sala sold 2,066 shares of the stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $56.66, for a total transaction of $117,059.56. The SEC filing for this sale provides additional information. Insiders sold 15,324 shares of company stock worth $855,019 over the last 90 days. Company insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On Exponent

Several institutional investors and hedge funds have recently modified their holdings of EXPO. United Services Automobile Association acquired a new stake in Exponent in the first quarter valued at approximately $270,000. Jane Street Group LLC grew its stake in Exponent by 1,481.0% in the 1st quarter. Jane Street Group LLC now owns 127,222 shares of the business services provider’s stock valued at $10,313,000 after acquiring an additional 119,175 shares during the period. Invesco Ltd. grew its stake in Exponent by 3.3% in the 2nd quarter. Invesco Ltd. now owns 554,733 shares of the business services provider’s stock valued at $41,444,000 after acquiring an additional 17,930 shares during the period. First Trust Advisors LP purchased a new stake in Exponent in the 2nd quarter worth $18,377,000. Finally, Walleye Capital LLC lifted its holdings in Exponent by 7.5% during the second quarter. Walleye Capital LLC now owns 6,623 shares of the business services provider’s stock valued at $495,000 after purchasing an additional 464 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Key Stories Impacting Exponent

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Q2 earnings and revenue exceeded expectations: Exponent reported adjusted earnings of $0.60 per share versus the $0.55 consensus estimate. Revenue reached approximately $171.6 million, while operating profit rose 63.1% year over year to $28.0 million. Exponent Q2 earnings report
• Positive Sentiment: Growth outlook raised: Management increased its 2026 net revenue growth forecast to 9%–10%, citing expanding demand for services related to artificial intelligence. The improved guidance reinforces expectations for continued business momentum. Exponent raises 2026 growth outlook
• Positive Sentiment: JPMorgan raised its price target: JPMorgan Chase increased its target from $80 to $90 and assigned an “overweight” rating, implying substantial potential appreciation from the referenced $66.94 price. JPMorgan raises Exponent price target
• Positive Sentiment: Capital returns increased: The board declared a quarterly dividend of $0.31 per share and expanded the company’s stock-repurchase authorization by $50 million. Exponent dividend and repurchase announcement
• Neutral Sentiment: The dividend offers an annualized yield of roughly 1.9%, with payment scheduled for September 18 to shareholders of record on September 4.
• Negative Sentiment: Insider-trading data showed 17 reported insider sales and no purchases over the past six months, which may raise a modest sentiment concern. Quarterly operating cash flow was also negative at $1.0 million, although capital spending remained limited at $2.5 million.

About Exponent

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.